CD8A and neoplasm: Furthermore, such in vivo assays have proven useful to pinpoint the reasons for immunotherapy failure, and could demonstrate for example how a fluorophore-conjugated PD-1 targeting antibody shown to target PD-1+ tumor infiltrating CD8 T-cells was immediately cleared by PD-1- tumor associated macrophages, preventing tumor regression (176).